FINWIRES · TerminalLIVE
FINWIRES

Research Alert: Boston Scientific Q1 2026: Strong Cardiovascular Growth, Solid U.s. Performance

By

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:

Boston Scientific delivered solid Q1 2026 results with net sales of $5.203B (+11.6% reported, +9.4% organic), continuing double-digit growth though at a more normalized pace versus exceptional 2025 levels. The quarter showed broad-based momentum with Cardiovascular generating $3.503B (+13.5% reported, +11.2% organic) and MedSurg contributing $1.701B (+7.8% reported, +5.7% organic). We view sustained Cardiovascular growth favorably, led by FARAPULSE adoption and structural heart solutions, underscoring leadership in high-growth markets. Management provided 2026 guidance with organic sales growth of 6.5%-8.0% and adjusted EPS of $3.34-$3.41, implying further deceleration but maintaining an above-market trajectory. We believe U.S. market strength with $3.284B in revenues (+10.9%) and standout Neuromodulation performance (+17.4% growth) support our positive outlook, while the active innovation pipeline with CHAMPION-AF trial successes positions Boston Scientific to sustain its competitive advantages.

Related Articles

Research

Research Alert: Bhp Raises Copper Outlook On Escondida Strength, Cuts Unit Costs Significantly

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:BHP delivered solid nine-month operational performance with copper production of 1,460.9kt, down 3% Y/Y, due to lower Escondida grades, while iron ore achieved record production of 196.6Mt, up 2%. Average realized copper prices surged 31% Y/Y to USD5.47/lb, led by AI infrastructure demand and electrification trends, with iron ore averaging USD84.91/wmt, up 2%. Strong operational momentum at key assets including record material mined at Escondida and excellence at WAIO support the investment thesis despite grade headwinds. Management upgraded FY 26 (Jun.) copper guidance to the upper half of the 1,900-2,000kt range, reflecting operational confidence. BHP's disciplined capital management realized USD4.8B through strategic transactions, including the Antamina streaming deal, enabling focus on growth projects. Escondida's unit cost guidance was lowered to USD1.00-1.20/lb, reflecting operational excellence, while the Resolution Copper land exchange milestone advances a major untapped copper resource.

$BHP
Research

Research Alert: CFRA Drops Stars Coverage Of Tripadvisor Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We are dropping analytical coverage of TRIP, an online travel agency, due to a shift in investor focus. Our previous recommendation on shares of TRIP was Hold.

$TRIP
Research

Research Alert: CFRA Drops Stars Coverage Of Six Flags Entertainment Corp

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We are dropping analytical coverage of FUN, an amusement park operator, due to a shift in investor focus. Our previous recommendation was Hold.

$FUN